NXTC NextCure, Inc. Common Stock

XNAS 11.38 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

NXTC $11.38 —
Key stats
$11.38
52-Week Range
$1.55 – $15.74
YTD
-14.31%
Straddle Price
$7.08
Market Cap
$0.0B
Open
$4.91
Day Range
$4.78 – $5.48
Volume
25,400
Prev Close
$4.98
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY1.03
Cost of Equity (CAPM)9.86% (VRP-adj)
WACC9.99%
Volatility Risk Premium-111.9pp (IV − HV30), ERP adj -25bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-351.9%
Book / Price57.9% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$6.15 (Market Anchor value)
SMA 20 / Bollinger Mid$5.76
Bollinger Width / SMA20937.4% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABT, NVS, PFE (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$10.62
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 39.5× · 3 peers
Peer EV/EBITDA n/a 0% median 19.2× · 3 peers
Peer P/B $10.62 100% median 3.5× · 3 peers
Peer P/S n/a 0% median 3.9× · 3 peers
Market Anchor (SMA50) $6.15 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-27 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
40
List Date
2019-05-09
CIK
0001661059
Next Earnings
2026-11-04 (Pre-Market)
EPS Forecast
($0.90) (1 est.)
Headquarters
Beltsville, MD
Homepage
https://www.nextcure.com

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The …

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan6.53%-10.74%12.08%6.09%-2.09%-18.30%-1.07%
Feb-5.25%-13.73%-4.91%33.08%0.84%16.38%4.40%
Mar-12.80%-1.22%-5.73%24.58%-34.12%-14.70%-7.33%
Apr-13.00%-16.13%0.67%-47.62%6.50%-12.54%-13.69%
May-8.08%-4.65%10.26%12.41%2.58%-33.76%-3.54%
Jun3.35%21.76%7.37%13.57%-4.23%-52.66%-1.81%
Jul-12.83%-4.44%-3.91%8.00%-5.20%111.48%15.52%
Aug8.86%-2.61%-14.12%-8.70%2.86%45.23%5.25%
Sep-10.01%-33.73%-9.15%-8.05%18.86%-26.32%-11.40%
Oct8.73%-9.42%-19.53%1.15%121.44%5.34%*17.95%
Nov-27.49%-43.60%10.28%-12.03%17.61%---11.05%
Dec-3.38%0.71%-5.00%-33.53%5.82%---7.08%
Total-52.68%-76.50%-24.32%-36.93%117.38%-46.98%-20.00%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $5.76
SMA 50: $6.15
SMA 200: $7.99
Current: $5.22
EMA 12: $5.59
EMA 26: $5.79
MACD: -0.1999 | Signal: -0.1259
BEARISH
ADX (14): 19.71
RANGE
+DI: 15.67
−DI: 19.81

Momentum Oscillators

RSI (14): 43.88
NEUTRAL
Stoch %K: 14.04
Stoch %D: 14.35
Williams %R: -76.74

Volume & Volatility

BB Upper: $7.32
BB Lower: $4.21
NEUTRAL
OBV: 116,892,426
Vol SMA 20: 66,435
Vol ROC: -80.52%
ATR: $0.81
True Range: $0.70
HV 20: 115.7%
HV 30: 111.9%
HV 60: 127.1%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
11 of 13 under expected move
Avg Expected Move
104.91%
Avg Actual Move
2.50%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-03-04 Pre-Market 0.76% 1.30% 1.71x Exceeded
2021-08-05 Pre-Market 2.37% 4.44% 1.87x Exceeded
2021-11-04 Pre-Market 0.81% 0.11% 0.14x Within
2022-03-03 Pre-Market 1.12% 1.04% 0.93x Within
2022-05-05 Pre-Market 5.80% 2.51% 0.43x Within
2023-05-04 Pre-Market 65.16% 4.61% 0.07x Within
2023-08-03 Pre-Market 32.67% 1.71% 0.05x Within
2023-11-02 Pre-Market 79.20% 9.35% 0.12x Within
2024-08-01 Pre-Market 229.94% 0.62% 0.00x Within
2024-11-07 After-Close 390.15% 2.27% 0.01x Within
2025-05-01 Pre-Market 107.43% 3.14% 0.03x Within
2025-08-07 Pre-Market 285.71% 1.26% 0.00x Within
2025-11-05 Pre-Market 162.75% 0.10% 0.00x Within

Earnings calendar: this week’s reports with expected vs actual moves →

NXTC Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $7.08
7-DTE Move: $7.08
Days to Exp: — (2025-12-19)

Options Flow

Call Volume: 0
Put Volume: 0
P/C Volume: —
Call OI: 3
Put OI: 0
P/C OI: —
Total OI: 3

ATM Options Pricing

ATM Call: $0.42
ATM Put: $6.65
Call %: 3.7%
Put %: 58.4%

Chain Summary

Chain Volume: 0
Chain OI: 3
Last Updated: 12/19/2025
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Dec 12 · No data
30 DTE / 10d —
— pts EXTREME
as of Dec 12 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$7.08Dec 19
Beta Analysis

Risk Metrics

Beta: 2.2048
Alpha: 89.24%
Correlation: 0.1177
R-Squared: 1.4%
Stock Volatility: 238.8%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own NXTC
2 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$274K
0.00%
#2804 of 3138+182.8%13F
Millennium Management Hedge fund
Izzy Englander
$141K
0.00%
#3556 of 3716new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

NXTC Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 4,016,881 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

31 filers1,828,025 shares$4.09M value45.51% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 91,910 $1.30M 31.91% 2.29% 2025-12-31
2 Ikarian Capital, LLC 288,303 $461.28K 11.29% 7.18% 2026-06-30
3 ADAGE CAPITAL PARTNERS GP, L.L.C. 277,202 $443.52K 10.85% 6.90% 2026-06-30
4 Sofinnova Investments, Inc. 222,654 $356.25K 8.72% 5.54% 2026-06-30
5 RENAISSANCE TECHNOLOGIES LLC 171,202 $273.92K 6.70% 4.26% 2026-06-30
6 Vanguard Capital Management LLC 156,842 $250.95K 6.14% 3.90% 2026-06-30
7 Millennium Management LLC Custodian 88,112 $140.98K 3.45% 2.19% 2026-06-30
8 BOOTHBAY FUND MANAGEMENT, LLC 84,687 $135.50K 3.32% 2.11% 2026-06-30
9 Squadron Capital Management LLC 64,464 $103.14K 2.52% 1.60% 2026-06-30
10 Verdad Advisers, LP 60,451 $96.72K 2.37% 1.50% 2026-06-30
11 Pfizer Inc 44,347 $72.97K 1.79% 1.10% 2026-06-30
12 Affinity Asset Advisors, LLC 41,960 $67.14K 1.64% 1.04% 2026-06-30
13 BlackRock, Inc. Custodian 37,348 $59.76K 1.46% 0.93% 2026-06-30
14 HRT FINANCIAL LP 36,450 $58.00K 1.42% 0.91% 2026-06-30
15 Jane Street Group, LLC Custodian 32,725 $52.36K 1.28% 0.81% 2026-06-30
16 Geode Capital Management, LLC Custodian 29,905 $47.85K 1.17% 0.74% 2026-06-30
17 CARDIFF PARK ADVISORS, LLC 21,833 $34.93K 0.85% 0.54% 2026-06-30
18 ACADIAN ASSET MANAGEMENT LLC 18,982 $30.00K 0.73% 0.47% 2026-06-30
19 Vanguard Fiduciary Trust Co 16,134 $25.81K 0.63% 0.40% 2026-06-30
20 NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 12,500 $20.00K 0.49% 0.31% 2026-06-30
21 Virtu Financial LLC 10,991 $18.00K 0.44% 0.27% 2026-06-30
22 DIADEMA PARTNERS LP 7,742 $12.39K 0.30% 0.19% 2026-06-30
23 Barclays PLC Custodian 5,726 $9.16K 0.22% 0.14% 2026-06-30
24 SBI Securities Co., Ltd. 1,000 $5.01K 0.12% 0.02% 2026-09-30
25 Persistent Asset Partners Ltd 1,981 $3.17K 0.08% 0.05% 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

NXTC Insider Trading (Form 4)

Latest: 2026-08-12
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-12 Jinsheng Ren Sell (S) −180,000 $6.16 -$1.11M EDGAR
2026-08-03 Daniel Schneeberger 10%+ Owner Buy (P) +658,306 $4.93 $3.25M EDGAR
2026-07-29 ADAR1 Capital Management, LLC 10%+ Owner Buy (P) +35,216 $4.98 $175.4K EDGAR
2026-06-22 Anne Elizabeth Borgman Director Grant (A) +2,340 opt — EDGAR
2026-06-22 Ellen Feigal Director Grant (A) +2,340 opt — EDGAR
2026-06-22 Elaine V Jones Director Grant (A) +2,340 opt — EDGAR
2026-06-22 David S Kabakoff Director Grant (A) +3,510 opt — EDGAR
2026-06-22 Stephen W Webster Director Grant (A) +2,340 opt — EDGAR
2026-06-22 John G Houston Director Grant (A) +2,340 opt — EDGAR
2026-02-03 Timothy Mayer Chief Operating Officer Grant (A) +14,670 opt — EDGAR
2026-02-03 Udayan Guha Chief Medical Officer Grant (A) +14,670 opt — EDGAR
2026-02-03 Kevin G. Shaw Sr VP, General Counsel Grant (A) +8,270 opt — EDGAR
2026-02-03 Sourav Kundu Sr VP, Dev. & Mfg. Grant (A) +8,270 opt — EDGAR
2026-02-03 Michael Richman President & CEO Grant (A) +38,190 opt — EDGAR
2026-02-03 Steven P. Cobourn Chief Financial Officer Grant (A) +14,670 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

NXTC Insider Holdings

3 insiders · @ $5.22
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Daniel Schneeberger 10%+ Owner 608,266 $3.18M $3.25M 1 2026-08-03
2 ADAR1 Capital Management, LLC 10%+ Owner 389,856 $2.04M $175.4K 1 2026-07-29
3 Jinsheng Ren 308,636 $1.61M -$1.11M 1 2026-08-12
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

NXTC Board & Officers

As of SEC filings through Aug 12, 2026

Directors 7

Officers 6

10% owners 2

Changes in the last 10 years (68)
Aug 12, 2026Simcere Zaiming, Inc. reported in an SEC filing no longer being a 10% owner
Aug 12, 2026Simcere Zaiming Pharmaceutical Co., Ltd. reported in an SEC filing no longer being a 10% owner
Aug 12, 2026Simcere Pharmaceutical Group Ltd reported in an SEC filing no longer being a 10% owner
Aug 12, 2026Renhong Tang reported in an SEC filing no longer being a 10% owner
Aug 12, 2026Jinsheng Ren reported in an SEC filing no longer being a 10% owner
Aug 12, 2026Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. reported in an SEC filing no longer being a 10% owner
Jul 27, 2026Daniel Schneeberger became a 10% owner
Jul 27, 2026ADAR1 Capital Management, LLC became a 10% owner
Aug 21, 2025The company announced the departure of Sol Langermann as Chief Scientific Officer in an SEC filing
Jun 20, 2025Simcere Zaiming, Inc. became a 10% owner
Jun 20, 2025Simcere Zaiming Pharmaceutical Co., Ltd. became a 10% owner
Jun 20, 2025Simcere Pharmaceutical Group Ltd became a 10% owner
Jun 20, 2025Renhong Tang became a 10% owner
Jun 20, 2025Jinsheng Ren became a 10% owner
Jun 20, 2025Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. became a 10% owner
Feb 1, 2025Udayan Guha became Chief Medical Officer
Jun 12, 2024The company announced the departure of Han Myint as Chief Medical Officer in an SEC filing
Feb 1, 2024Kevin G. Shaw listed as Sr VP, General Counsel (previously Sr VP, Legal Affairs) in SEC filings
Jul 15, 2023The company announced the departure of Garry A Nicholson from the board in an SEC filing
Feb 24, 2023Kevin G. Shaw became Sr VP, Legal Affairs
Not reported recently (11)
  • Chau Quang Khuong · Last reported as a director in an SEC filing dated Jun 23, 2023
  • Linda Liu · Last reported as SVP, Research in an SEC filing dated Feb 2, 2022
  • Stella Xu · Last reported as a director in an SEC filing dated Jun 28, 2021
  • Kevin N. Heller · Last reported as Chief Medical Officer in an SEC filing dated Jul 16, 2020
  • Briggs Morrison · Last reported as a director in an SEC filing dated Jun 15, 2020
  • Judith Li · Last reported as a director in an SEC filing dated Jun 15, 2020
  • James B. Bingham · Last reported as Chief Development Officer in an SEC filing dated Mar 3, 2020
  • Timothy M Shannon · Last reported as a director in an SEC filing dated Jun 17, 2019
  • Orbimed Advisors LLC · Last reported as a director in an SEC filing dated May 13, 2019
  • OrbiMed Capital GP VI LLC · Last reported as a director in an SEC filing dated May 13, 2019
  • Quan Venture Fund II, L.P. · Last reported as a 10% owner in an SEC filing dated May 8, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
5 ETFs hold NXTC
5 shown · $854.06K total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $617,613 — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $168,166 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.00% $54,496 $1.2B 2026-10-23
4 DFMC Dimensional US Micro Cap ETF Dimensional 0.00% $13,496 — 2026-10-23
5 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.00% $294 — 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-8.70
TTM Revenue
—
TTM Net Income
$-42.75M
TTM Op. Cash Flow
$-36.98M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30—$-14.89M$-2.80$-9.71M
Q1 '262026-03-31—$-9.80M$-1.87$-13.36M
Q4 '252025-12-31—$-9.44M$-0.81$-7.64M
Q3 '252025-09-30—$-8.62M$-3.22$-6.27M
Q2 '252025-06-30—$-26.81M$-11.29$-22.71M
Q1 '252025-03-31—$-10.98M$-4.70$-12.99M
Q4 '242024-12-31—$-11.60M$-4.97$-6.97M
Q3 '242024-09-30—$-11.54M$-4.95$-11.45M
Q2 '242024-06-30—$-15.40M$-6.61$-9.78M
Q1 '242024-03-31—$-17.11M$-7.32$-12.61M
Q4 '232023-12-31—$-14.47M$-6.24$-10.67M
Q3 '232023-09-30—$-14.30M$-6.12$-12.78M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-06
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.73
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-351.9%
ROA
-189.0%
Div Yield
0.00%
FCF Yield
-176.21%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$20.99M
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
213.31K
SI % of Float
8.08%
Days to Cover
1.86
Short Vol Ratio
20.7%
Free Float
2.64M
Float %
73.1%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-14